Cargando…

Use of targeted therapies for advanced renal cell carcinoma in the Veterans Health Administration

BACKGROUND: The objective of this study is to describe the use of targeted therapies for the treatment of advanced renal cell carcinoma (RCC) and overall survival (OS) among patients in clinical practice in the Veterans Health Administration (VHA). METHODS: A retrospective cohort of 286 patients fro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aspinall, Sherrie L., Zhao, Xinhua, Geraci, Mark C., Good, Chester B., Cunningham, Francesca E., Heron, Bernadette B., Becker, Daniel, Lee, Steve, Prasad, Vinay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825975/ https://www.ncbi.nlm.nih.gov/pubmed/31536684 http://dx.doi.org/10.1002/cam4.2531

Ejemplares similares

Glycemic Control Was Unchanged in Veterans Health Administration Patients Converted from Glyburide to Glipizide
por: Aspinall, Sherrie L., et al.
Publicado: (2012)

Cost-Effectiveness Analysis of Adjuvant Stage III Colon Cancer Treatment at Veterans Affairs Medical Centers
por: Soni, Amy, et al.
Publicado: (2015)

Pharmacy Benefits Management in the Veterans Health Administration Revisited: A Decade of Advancements, 2004-2014
por: Aspinall, Sherrie L., et al.
Publicado: (2016)

Evaluation of Clostridium difficile-Associated Diarrhea With a Drug Formulary Change in Preferred Fluoroquinolones
por: Walbrown, Molly A., et al.
Publicado: (2008)

Estimated Costs of Severe Adverse Drug Reactions Resulting in Hospitalization in the Veterans Health Administration
por: Aspinall, Sherrie L., et al.
Publicado: (2022)

Adjuvant chemotherapy for stage III colon cancer: relative dose intensity and survival among veterans
por: Aspinall, Sherrie L, et al.
Publicado: (2015)

Preventing Hepatitis B Reactivation During Anti‐CD20 Antibody Treatment in the Veterans Health Administration
por: Jasmine Bullard, A., et al.
Publicado: (2018)

Treatment patterns and survival in metastatic castration‐sensitive prostate cancer in the US Veterans Health Administration
por: Freedland, Stephen J., et al.
Publicado: (2021)

Utility of bevacizumab in advanced hepatocellular carcinoma: A veterans affairs experience
por: Wattenberg, Max M., et al.
Publicado: (2019)

Major hemorrhage in chronic lymphocytic leukemia patients in the US Veterans Health Administration system in the pre‐ibrutinib era: Incidence and risk factors
por: Georgantopoulos, Peter, et al.
Publicado: (2019)

Maintenance rituximab in Veterans with follicular lymphoma
por: Halwani, Ahmad S., et al.
Publicado: (2020)

Assessment of Use and Safety of Edaravone for Amyotrophic Lateral Sclerosis in the Veterans Affairs Health Care System
por: Vu, Michelle, et al.
Publicado: (2020)

Tight Glycemic Control and Use of Hypoglycemic Medications in Older Veterans With Type 2 Diabetes and Comorbid Dementia
por: Thorpe, Carolyn T., et al.
Publicado: (2015)

Varenicline and Nicotine Replacement Use Associated With US Food and Drug Administration Drug Safety Communications
por: Desai, Ravi J., et al.
Publicado: (2019)

Determinants of quality prostate cancer survivorship care across the primary and specialty care interface: Lessons from the Veterans Health Administration
por: Radhakrishnan, Archana, et al.
Publicado: (2019)

Health Equity in Patients Receiving Durvalumab for Unresectable Stage III Non-Small Cell Lung Cancer in the US Veterans Health Administration
por: Moore, Amanda M, et al.
Publicado: (2023)

Incidence and survival for oropharynx and non‐oropharynx head and neck cancers among veterans living with HIV
por: Mazul, Angela L., et al.
Publicado: (2020)

Does Greater Continuity of Veterans Administration Primary Care Reduce Emergency Department Visits and Hospitalization in Older Veterans?
por: Katz, David A., et al.
Publicado: (2015)

Effect of Deintensifying Diabetes Medications on Negative Events in Older Veteran Nursing Home Residents
por: Niznik, Joshua D., et al.
Publicado: (2022)

Disparities in Anticoagulant Therapy Initiation for Incident Atrial Fibrillation by Race/Ethnicity Among Patients in the Veterans Health Administration System
por: Essien, Utibe R., et al.
Publicado: (2021)

Pharmacokinetics of doxorubicin following concomitant intravenous administration of olaratumab (IMC‐3G3) to patients with advanced soft tissue sarcoma
por: Villalobos, Victor M., et al.
Publicado: (2019)

Variation in Formulary Management Practices Within the Department of Veterans Affairs Health Care System
por: Radomski, Thomas R., et al.
Publicado: (2016)

Survival among patients with advanced renal cell carcinoma in the pretargeted versus targeted therapy eras
por: Li, Pengxiang, et al.
Publicado: (2015)

The impact of primary tumor sidedness on survival in early‐onset colorectal cancer by stage: A National Veterans Affairs retrospective analysis
por: Azar, Ibrahim, et al.
Publicado: (2021)

Outpatient administration of BEAM conditioning prior to autologous stem cell transplantation for lymphoma is safe, feasible, and cost‐effective
por: Reid, Robin M., et al.
Publicado: (2016)

The effect of pre-existing mental health comorbidities on the stage at diagnosis and timeliness of care of solid tumor malignances in a Veterans Affairs (VA) medical center
por: Wadia, Roxanne J, et al.
Publicado: (2015)

Clinical outcomes in patients with metastatic renal cell carcinoma and brain metastasis treated with ipilimumab and nivolumab
por: Brown, Landon C., et al.
Publicado: (2021)

Provider and clinical setting characteristics associated with tobacco pharmacotherapy dispensed in the Veterans Health Administration
por: Blok, Amanda C., et al.
Publicado: (2021)

Fatigue in patients with advanced renal cell carcinoma receiving sunitinib on an intermittent versus continuous dosing schedule in a randomized phase II trial
por: Cella, David, et al.
Publicado: (2014)

A system‐based intervention to reduce Black‐White disparities in the treatment of early stage lung cancer: A pragmatic trial at five cancer centers
por: Cykert, Samuel, et al.
Publicado: (2019)

IMPACT OF COVID-19 PANDEMIC ON DIAGNOSIS AND TREATMENT OF LUNG CANCER IN THE VETERAN COHORT
por: ABBAS, HATOON, et al.
Publicado: (2021)

Origins and Timing of Emerging Lesions in Advanced Renal Cell Carcinoma
por: Wallace, Andrew, et al.
Publicado: (2022)

Update on combined immunotherapy for the treatment of advanced renal cell carcinoma
por: Gebrael, Georges, et al.
Publicado: (2023)

Combination antiangiogenic tyrosine kinase inhibition and anti‐PD1 immunotherapy in metastatic renal cell carcinoma: A retrospective analysis of safety, tolerance, and clinical outcomes
por: Laccetti, Andrew L., et al.
Publicado: (2021)

Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancer
por: DeMaria, Peter J, et al.
Publicado: (2021)

Outcomes for Muscle-invasive Bladder Cancer with Radical Cystectomy or Trimodal Therapy in US Veterans
por: Kumar, Abhishek, et al.
Publicado: (2021)

Transgender Veterans and the Veterans Health Administration: Exploring the Experiences of Transgender Veterans in the Veterans Affairs Healthcare System
por: Rosentel, Kris, et al.
Publicado: (2016)

Serious cardiovascular adverse events with fluoroquinolones versus other antibiotics: A self‐controlled case series analysis
por: Aspinall, Sherrie L., et al.
Publicado: (2020)

Infertility Services for Veterans Enrolled in Veterans Health Administration Care
por: Kroll-Desrosiers, Aimee, et al.
Publicado: (2023)

Facilitating Veterans Health Administration Primary Care for Transitioning Servicemembers: a Novel Virtual Care Clinic
por: Kumar, Sumit R., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7sqcfc5joov5vhi75elb0o25cl